Literature DB >> 15211651

Cohen syndrome in the Ohio Amish.

Marni J Falk1, Heidi S Feiler, Derek E Neilson, Kathleen Maxwell, James V Lee, Samantha K Segall, Nathaniel H Robin, Kirk C Wilhelmsen, Ann-Liz Träskelin, Juha Kolehmainen, Anna-Elina Lehesjoki, Max Wiznitzer, Matthew L Warman.   

Abstract

We describe eight members from two large Amish kindreds who share a phenotype characterized by early-onset pigmentary retinopathy and myopia, global developmental delay and mental retardation, microcephaly, short stature, hypotonia, joint hyperextensibility, small hands and feet, common facial appearance, and friendly disposition. Several of the children had intermittent granulocytopenia. The phenotypic occurrence in three siblings coupled with the increased coefficient of inbreeding in the Amish suggested that this disorder is autosomal recessive and due to a single founder allele. Despite similarity to the clinical features of Cohen syndrome, experienced dysmorphologists attending the 23rd David W. Smith Workshop suggested the facial gestalt of the Amish children was inconsistent with this diagnosis. We mapped the locus responsible for these individuals' phenotype to chromosome 8q22-q23, which contains the recently discovered Cohen syndrome gene, COH1. Complete sequencing of the COH1 gene identified a likely disease-causing frameshift mutation and a missense mutation in the Amish patients. A comparison of features among different Cohen syndrome populations with shared linkage to the COH1 locus or known COH1 gene mutations may allow for the determination of improved clinical criteria on which to suspect the diagnosis of Cohen syndrome. We conclude that facial gestalt seems to be an unreliable indicator of Cohen syndrome between ethnic populations, although it is quite consistent among affected individuals within a particular ethnic group. Other features common to almost all individuals with proven COH1 mutations, such as retinal dystrophy, myopia, microcephaly, mental retardation, global developmental delay, hypotonia, and joint hyperextensibility appear to be better clinical indicators of this disorder. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211651     DOI: 10.1002/ajmg.a.30033

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

1.  Mutational spectrum of COH1 and clinical heterogeneity in Cohen syndrome.

Authors:  W Seifert; M Holder-Espinasse; S Spranger; M Hoeltzenbein; E Rossier; H Dollfus; D Lacombe; A Verloes; K H Chrzanowska; G H B Maegawa; D Chitayat; D Kotzot; D Huhle; P Meinecke; B Albrecht; I Mathijssen; B Leheup; K Raile; H C Hennies; D Horn
Journal:  J Med Genet       Date:  2006-05       Impact factor: 6.318

2.  High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome.

Authors:  Veronica Parri; Eleni Katzaki; Vera Uliana; Francesca Scionti; Rossella Tita; Rosangela Artuso; Ilaria Longo; Renske Boschloo; Raymon Vijzelaar; Angelo Selicorni; Francesco Brancati; Bruno Dallapiccola; Leopoldo Zelante; Christian P Hamel; Pierre Sarda; Seema R Lalani; Rita Grasso; Sabrina Buoni; Joussef Hayek; Laurent Servais; Bert B A de Vries; Nelly Georgoudi; Sheena Nakou; Michael B Petersen; Francesca Mari; Alessandra Renieri; Francesca Ariani
Journal:  Eur J Hum Genet       Date:  2010-05-12       Impact factor: 4.246

3.  Vps13b is required for acrosome biogenesis through functions in Golgi dynamic and membrane trafficking.

Authors:  Romain Da Costa; Morgane Bordessoules; Magali Guilleman; Virginie Carmignac; Vincent Lhussiez; Hortense Courot; Amandine Bataille; Amandine Chlémaire; Céline Bruno; Patricia Fauque; Christel Thauvin; Laurence Faivre; Laurence Duplomb
Journal:  Cell Mol Life Sci       Date:  2019-06-19       Impact factor: 9.261

4.  Disease relevance of rare VPS13B missense variants for neurodevelopmental Cohen syndrome.

Authors:  Malte Zorn; Jirko Kühnisch; Sebastian Bachmann; Wenke Seifert
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

5.  Clinical and molecular characterization of Italian patients affected by Cohen syndrome.

Authors:  Eleni Katzaki; Chiara Pescucci; Vera Uliana; Filomena Tiziana Papa; Francesca Ariani; Ilaria Meloni; Manuela Priolo; Angelo Selicorni; Donatella Milani; Rita Fischetto; Maria Elena Celle; Rita Grasso; Bruno Dallapiccola; Francesco Brancati; Marta Bordignon; Romano Tenconi; Antonio Federico; Francesca Mari; Alessandra Renieri; Ilaria Longo
Journal:  J Hum Genet       Date:  2007-11-08       Impact factor: 3.172

6.  Changing facial phenotype in Cohen syndrome: towards clues for an earlier diagnosis.

Authors:  Salima El Chehadeh-Djebbar; Edward Blair; Muriel Holder-Espinasse; Anne Moncla; Anne-Marie Frances; Marlène Rio; François-Guillaume Debray; Patrick Rump; Alice Masurel-Paulet; Nadège Gigot; Patrick Callier; Laurence Duplomb; Bernard Aral; Frédéric Huet; Christel Thauvin-Robinet; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2012-11-28       Impact factor: 4.246

Review 7.  Ocular involvement in primary immunodeficiency diseases.

Authors:  Sima Hosseinverdi; Hassan Hashemi; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal:  J Clin Immunol       Date:  2013-11-30       Impact factor: 8.542

Review 8.  Cohen Syndrome: Review of the Literature.

Authors:  Jonathan M Rodrigues; Hermina D Fernandes; Carrie Caruthers; Stephen R Braddock; Alan P Knutsen
Journal:  Cureus       Date:  2018-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.